The Awareness of Methylphenidate and Its Use: Experiences and Perceptions of Medical Students
Burak Onal1, Melik Yigit Bayindir2, Yasemin Begum Topkarci1
1Medical Pharmacology, Biruni University Faculty of Medicine, Istanbul, TUR.
Abstract:
Background and objective Over the past decade, the use of psychostimulants typically prescribed for attention-deficit/hyperactivity disorder (ADHD), such as methylphenidate (MP), has become popular among undergraduate students to enhance their academic performance. Despite potential health and legal repercussions, the misuse of these medications has become a significant public health issue, not only in the general population but particularly among students in medical schools across Turkey. This study investigated the prevalence of MP misuse among Turkish medical students and the factors contributing to it. Methods We conducted a survey involving 418 medical students (257 female, 161 male), covering addiction history, physician-recommended ADHD medication, sharing and recommending MP among peers, initial exposure to MP misuse information, reasons for non-prescription MP use, duration of misuse, perceptions of MP's addictive potential, and ethical views on MP use to help with exams. Results The findings revealed that senior students showed a higher level of awareness and earlier initiation of MP misuse compared to younger students (p<0.05). Residing in student housing emerged as a significant reason for exposure to and subsequent misuse of non-medical prescription MP (p<0.05). Both MP misusers and non-users acknowledged the MP's addictive nature. Peer influence was the primary factor for initial recommendations of MP misuse (p<0.05). Conclusions While academic achievement appears to be the primary motivator for MP misuse, the effectiveness of this practice in non-ADHD students is uncertain. Implementing proactive measures is crucial to curb such misuse, particularly among medical students, to prevent a future global health concern.
More Related Videos
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
